SpringerLink
Log in

The role of tumor suppressor gene SOX11 in prostate cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

SOX genes play an important role in a number of developmental processes. The transcription factor SOX11 is one of the members of the SOX family emerging as important transcriptional regulators. The aim of this study was to investigate the role of SOX11 in prostate cancer (PCa) and its expression pattern and clinical significance. The gene expression of SOX11 in human PCa tissues compared with benign prostate hyperplasia (BPH) tissues was detected using real-time quantitative reverse transcriptase-polymerase chain reaction (QRT-PCR) analysis and immunohositochemistry. SOX11 overexpression cell model was used to examine the role of SOX11 in cell growth and metastasis in vitro. The results showed that the positive rate of SOX11 staining was 16.67 % (10/60) in cases of prostatic carcinoma and 81.67 % (49/60) in cases of BPH, and the difference of SOX11 expression between PCa and BPH was statistically significant (P < 0.001). SOX11 mRNA level was lowly expressed in PCa cell lines compared to RWPE-1. SOX11 overexpression suppresses PCa cell migration and invasion. In conclusion, our findings demonstrate that SOX11 could suppress cell proliferation, migration, and invasion of PCa in vitro.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765–81.

    Article  CAS  PubMed  Google Scholar 

  2. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, et al. EAU guidelines on prostate cancer. Part1: screening, diagnosis, and treatment of clinically localized disease. Eur Urol. 2011;59(1):61–71.

    Article  PubMed  Google Scholar 

  3. Saad F, Pantel K. The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer. Future Oncol. 2012;8(3):321–31.

    Article  CAS  PubMed  Google Scholar 

  4. Titulaer MJ, Klooster R, Potman M, Sabater L, Graus F, Hegeman IM, et al. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival. J Clin Oncol. 2009;27:4260–7.

    Article  CAS  PubMed  Google Scholar 

  5. Wang H, McKnight NC, Zhang T, Lu ML, Balk SP, Yuan X. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells. Cancer Res. 2007;67:528–36.

    Article  CAS  PubMed  Google Scholar 

  6. Sock E, Rettig SD, Enderich J, Bosl MR, Tamm ER, Wegner M. Gene targeting reveals a widespread role for the high-mobility-group transcription factor Sox11 in tissue remodeling. Mol Cell Biol. 2004;24:6635–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Royo C, Salaverria I, Hartmann EM, Rosenwald A, Campo E, Bea S. The complex landscape of genetic alterations in mantle cell lymphoma. Semin Cancer Biol. 2011;21(5):322–34.

    Article  CAS  PubMed  Google Scholar 

  8. Zeng W, Fu K, Quintanilla-Fend L, Lim M, Ondrejka S, Hsi ED. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression. Am J Surg Pathol. 2012;36:214–9.

    Article  PubMed  Google Scholar 

  9. Cao B, Qi Y, Yang Y, Liu X, Xu D, Guo W, et al. 20(S)-protopanaxadiol inhibition of progression and growth of castration-resistant prostate cancer. PLoS One. 2014;9(11):e111201.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Hargrave M, Wright E, Kun J, Emery J, Cooper L, Koopman P. Expression of the Sox11 gene in mouse embryos suggests roles in neuronal maturation and epithelio-mesenchymal induction. Dev Dyn. 1997;210:79–86.

    Article  CAS  PubMed  Google Scholar 

  11. Haslinger A, Schwarz TJ, Covic M, Chichung Lie D. Expression of Sox11 in adult neurogenic niches suggests a stage-specific role in adult neurogenesis. Eur J Neurosci. 2009;29:2103–14.

    Article  PubMed  Google Scholar 

  12. Jankowski MP, Cornuet PK, McIlwrath S, Koerber HR, Albers KM. SRY-box containing gene 11 (SOX11) transcription factor is required for neuron survival and neurite growth. Neuroscience. 2006;143:501–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Sernbo S, Gustavsson E, Brennan DJ, Gallagher WM, Rexhepaj E, Rydnert F, et al. The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation. BMC Cancer. 2011;11:405.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Korkolopoulou P, Levidou G, El-Habr EA, Adamopoulos C, Fragkou P, Boviatsis E, et al. Sox11 expression in astrocytic gliomas: correlation with nestin/c-Met/IDH1-R132H expression phenotypes, p-Stat-3 and survival. Br J Cancer. 2013;108(10):2142–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Vegliante MC, Palomero J, Pérez-Galán P, Roué G, Castellano G, Navarro A, et al. SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma. Blood. 2013;121(12):2175–85.

    Article  CAS  PubMed  Google Scholar 

  16. Delot EC, Bahamonde ME, Zhao M, Lyons KM. BMP signaling is required for septation of the outflow tract of the mammalian heart. Development. 2003;130:209–20.

    Article  CAS  PubMed  Google Scholar 

  17. Gustavsson E, Sernbo S, Andersson E, et al. SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Mol Cancer. 2010;9:187.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Urology, Air Force General Hospital of PLA, No.30 Fu Cheng Road, Bei**g, 100142, China

    Zhiyong Yao, Bin Sun, Quan Hong, **gmin Yan, Dawei Mu, Jianye Li, Haibo Sheng & Heqing Guo

Authors
  1. Zhiyong Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bin Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Quan Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. **gmin Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dawei Mu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jianye Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Haibo Sheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Heqing Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Heqing Guo.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yao, Z., Sun, B., Hong, Q. et al. The role of tumor suppressor gene SOX11 in prostate cancer. Tumor Biol. 36, 6133–6138 (2015). https://doi.org/10.1007/s13277-015-3296-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3296-3

Keywords

Search

Navigation